[1]胡勇 张惜燕 吴雪.黄芪干预骨质疏松症的实验研究进展*[J].现代中医药,2023,(06):008-12.[doi:10.13424/j.cnki.mtcm.2023.06.002]
点击复制

黄芪干预骨质疏松症的实验研究进展*()
分享到:

《现代中医药》[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2023年06期
页码:
008-12
栏目:
出版日期:
2023-12-08

文章信息/Info

文章编号:
1672-0571(2023)06-0008-05
作者:
胡勇 张惜燕 吴雪
陕西中医药大学,陕西 咸阳 712046
关键词:
关键词:骨质疏松症黄芪骨质疏松症模型作用机制研究进展
分类号:
R285.5;R274.9
DOI:
10.13424/j.cnki.mtcm.2023.06.002
文献标志码:
A
摘要:
摘 要:综述近几年黄芪在骨质疏松症(Osteoporosis,OP)实验中的研究进展,指出黄芪对老年性OP、绝经后OP、糖皮质激素性OP及糖尿病性OP均有较好的缓解作用;其有效物质基础为黄芪多糖、黄芪甲苷、刺芒柄花素;其抗OP作用机制包括促进成骨细胞增殖、抑制破骨细胞活性、调节雌激素水平、抗氧化应激反应、改善肠道菌群等,以期为研究者深入开发黄芪及活性成分提供参考。

参考文献/References:

[1]Seriolo B,Paolino S,Casabella A,et al.Osteoporosis in the elderly[J].Aging Clinical and Experimental Research,2013,25(1):27-29.
[2]杜丽坤,李佳睿.骨质疏松症的中医认识及防治[J].中国骨质疏松杂志,2022,28(2):296-299.
[3]Salari N,Darvishi N,Bartina Y,et al.Global prevalence of osteoporosis among the world older adults:a comprehensive systematic review and meta-analysis[J].Journal of Orthopaedic Surgery and Research,2021,16(1):669.
[4]杨成,吴斗,刘强.骨质疏松症流行病学、影响因素及其相关机制研究进展[J].中国骨与关节杂志,2023,12(4):306-310.
[5]国家药典委员会.中华人民共和国药典[S].北京:中国医药科技出版社,2020:315.
[6]张淑娟,张育贵,牛江涛,等.黄芪的研究进展及其质量标志物预测分析[J].中华中医药学刊,2022,40(2):151-155.
[7]裘越,喻嵘,熊韬,等.中医药治疗原发性骨质疏松的用药规律[J].中国骨质疏松杂志,2022,28(1):75-79.
[8]Takeda T.Senescence-accelerated mouse (SAM):a biogerontological resource in aging research[J].Neurobiology of Aging,1999,20(2):105-110.
[9]蔡林秀,常俊杰,解强,等.唑来膦酸拮抗D-半乳糖诱导成骨细胞损伤的作用[J].中国医学创新,2022,19(7):27-32.
[10]梁美婷,吕思敏,王可欣,等.用Micro CT评价D-半乳糖致雄性小鼠骨质疏松模型及骨化三醇的防治作用[J].中国药理学通报,2019,35(3):391-395.
[11]Chai YH,Pu X,Wu YZ,et al.Inhibitory effect of Astragalus Membranaceus on osteoporosis in SAMP6 mice by regulating vitaminD/FGF23/Klotho signaling pathway[J].Bioengineered,2021,12(1):4464-4474.
[12]Pu X,Chai YH,Guan LC,et al.Astragalus improve aging bone marrow mesenchymal stem cells (BMSCs) vitality and osteogenesis through VD-FGF23-Klotho axis[J].International Journal of Clinical and Experimental Pathology,2020,13(4):721-729.
[13]王焕珍,田永松,杨殿忠,等.黄芪含药血清对D-半乳糖诱导大鼠衰老骨髓间充质干细胞维生素D-FGF23-Klotho轴的影响[J].时珍国医国药,2020,31(8):1833-1836.
[14]李倩,吴雍真,管连城,等.黄芪含药血清对衰老骨髓间充质干细胞CYP24A1,CYP27B1 mRNA和蛋白的影响[J].中国实验方剂学杂志,2020,26(17):49-55.
[15]毛幸,楼超,周晓明.围绝经期骨质疏松与血清维生素D、雌激素水平的相关性分析[J].中国妇幼保健,2019,34(17):4002-4005.
[16]Pereira CS,Stringhetta-Garcia CT,da Silva Xavier L,et al.llex paraguariensis decreases oxidative stress in bone and mitigates the damage in rats during perimenopause[J].Experimental Gerontology,2017,98:148-152.
[17]Ahmad J,Sharma T,Islam N,et al.Correlation between bone mineral density and oxidative stress in postmenopausal women[J].Indian Journal of Endocrinology and Metabolism,2015,19(4):491.
[18]Callaway DA,Jiang JX.Reactive oxygen species and oxidative stress in osteoclastogenesis,skeletal aging and bone diseases[J].Journal of Bone and Mineral Metabolism,2015,33(4):359-370.
[19]Liu HR,Xiong YQ,Zhu XF,et al.Icariin improves osteoporosis,inhibits the expression of PPARγ,C/EBPα,FABP4 mRNA,N1ICD and jagged1 proteins,and increases Notch2 mRNA in ovariectomized rats[J].Experimental and Therapeutic Medicine,2017,13(4):1360-1368.
[20]崔红,贾文斌,杨奇,等.黄芪治疗绝经后骨质疏松的抗氧化机制研究[J].国际妇产科学杂志,2015,42(5):504-507.
[21]张小钰,陈慧,马敬祖,等.黄芪多糖治疗对去卵巢诱导骨质疏松大鼠骨密度、骨量和骨代谢的影响[J].中国骨质疏松杂志,2021,27(1):21-25.
[22]Ou L,Wei PF,Li M,et al.Inhibitory effect of Astragalus polysaccharide on osteoporosis in ovariectomized rats by regulating FoxO3a/Wnt signaling pathway[J].Acta Cirurgica Brasileira,2019,34(5):e201900502.
[23]翟鑫祥,董辉,王晶,等.黄芪多糖保护去卵巢大鼠成骨细胞功能活性的机制研究[J].天津医药,2022,50(3):265-269.
[24]Huo J,Sun X.Effect of Astragalus polysaccharides on ovariectomy-induced osteoporosis in mice[J].Genetics and Molecular Research:GMR,2016,15(4).DOI:10.4238/gmr15049169.
[25]成鹏,白银亮,胡彩莉,等.黄芪甲苷通过调控FoxO3a/Wnt2/β-catenin通路抑制去卵巢大鼠骨质疏松的作用[J].中国实验方剂学杂志,2018,24(15):161-166.
[26]马天成,孙宇,张金玲,等.UPLC-MS同时测定黄芪中10种化合物含量[J].中药材,2019,42(4):838-844.
[27]喻琴云,詹晓峰,黄彦.刺芒柄花素对去势骨质疏松大鼠P38MAPK/MMP-9信号通路的影响[J].中国临床药理学与治疗学,2017,22(12):1371-1376.
[28]Oray M,Abu Samra K,Ebrahimiadib N,et al.Long-term side effects of glucocorticoids[J].Expert Opinion on Drug Safety,2016,15(4):457-465.
[29]胡勇,张惜燕,吴雪.固本活血壮骨颗粒对糖皮质激素性骨质疏松症大鼠的作用与机制[J].中国骨质疏松杂志,2023,29(7):960-965,975.
[30]Huang JS,Ye YJ,Xiao YS,et al.Geniposide ameliorates glucocorticoid-induced osteoblast apoptosis by activating autophagy[J].Biomedicine & Pharmacotherapy=Biomedecine & Pharmacotherapie,2022,155:113829.
[31]蒲翔,田兴中,顾春松,等.黄芪多糖对地塞米松诱导的MC-3T3-E1成骨细胞增殖抑制及Bax、Caspase-3、VDR、CYP24A、CYP27B蛋白表达的影响[J].时珍国医国药,2020,31(12):2850-2853.
[32]孙文星,黄万新,刘传慧,等.黄芪多糖通过PI3K/AKT/mTOR促进激素性骨质疏松症大鼠成骨细胞增殖[J].中国骨质疏松杂志,2023,29(1):35-40.
[33]Liu JS,Liu J,Liu L,et al.The gut microbiota alteration and the key bacteria in Astragalus polysaccharides (APS)-improved osteoporosis[J].Food Research International,2020,138(Pt B):109811.
[34]Liu JS,Liu J,Duan S,et al.Reprogrammed epigenetic landscape-prophesied functions of bioactive polysaccharides in alleviating diseases:a pilot study of DNA methylome remodeling in Astragalus polysaccharide (APS)-improved osteoporosis in a rat model[J].Journal of Agricultural and Food Chemistry,2020,68(52):15449-15459.
[35]佀思聪,杨伟,王洁妤,等.老年2型糖尿病患者血糖波动与骨质疏松症[J].中华保健医学杂志,2023,25(1):66-69.
[36]唐辉,姚志浩,罗道文,等.高脂高糖饮食结合链脲佐菌素建立2型糖尿病性骨质疏松症大鼠模型[J].中国组织工程研究,2021,25(8):1207-1211.
[37]An YN,Zhang HF,Wang C,et al.Activation of ROS/MAPKs/NF-κB/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis[J].The FASEB Journal,2019,33(11):12515-12527.
[38]滕腾,孙鑫,张冉,等.黄芪多糖对高糖环境下MC3T3-E1细胞活性影响的研究[J].牙体牙髓牙周病学杂志,2015,25(6):348-353,341.
[39]Jing WS,Feng L,Peng K,et al.Formononetin attenuates osteoclast differentiation and calcium loss by mediating transcription factor AP-1 in type I diabetic mice[J].Journal of Biochemical and Molecular Toxicology,2022,36(6):e23042.
[40]侯伟,万趸.刺芒柄花素对Ⅱ型糖尿病大鼠骨质疏松的缓解作用[J].实验动物与比较医学,2020,40(3):232-235.

相似文献/References:

[1]李国臣 张盛君 王 森.试述黄芪在气虚方证中的配伍应用[J].现代中医药,2017,(03):071.[doi:10.13424/j.cnki.mtcm.2017.03.028]
[2]于航星 雷根平*.雷根平主任医师重用黄芪治疗肾性水肿举隅[J].现代中医药,2017,(05):009.[doi:10.13424/j.cnki.mtcm.2017.05.004]
[3]杨锋 张磊.原发性骨质疏松症中医诊疗方案解读*[J].现代中医药,2023,(02):020.[doi:10.13424/j.cnki.mtcm.2023.02.004]

备注/Memo

备注/Memo:
基金项目:陕西省教育厅重点科研计划项目(23JS006,20JS029);陕西中医药大学中医经典理论研究创新团队资助项目(2019-YL01)
更新日期/Last Update: 2023-11-23